重组人LILRA6/CD85b/ILT8(His Avi标签)蛋白|Human LILRA6/CD85b/ILT8(93492ES)
产品应用
LILRA6, also known as ILT8 and CD85b, is a transmembrane molecule that belongs to the LILR family of immune regulatory proteins. Among family members, LILRA6 is most closely related to LILRB3/CD85a/ILT5; these proteins share 94% amino acid (aa) sequence identity in their extracellular domains (ECD). Mature human LILRA6 consists of a 424 aa ECD with two immunoglobulin-like domains, a 21 aa transmembrane segment, and a 13 aa cytoplasmic domain. It contains a positively charged arginine residue in the transmembrane segment which may mediate association with the signaling protein Fc epsilon RI gamma. Alternative splicing generates a short isoform that is truncated near the middle of the ECD. LILRA6 is highly polymorphic, and its gene is found in variably copy numbers. LILRA6 is primarily expressed on monocytes.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白
380
2026-08-31
【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白
433
2026-08-31
【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白
445
2026-08-31
【文献解读】Science 重磅成果:西湖大学团队攻克共价蛋白药物核心瓶颈,建立通用高通量速效蛋白筛选平台
638
2026-06-25
【技术讲解】信号通路系列 | Wnt/β-catenin信号通路:细胞的“信号转换器”与“命运规划师”
911
2026-04-29
【文献解读】EGFR信号通路的耐药新视角:当EGFR-TKI遇上免疫压力,肿瘤如何“金蝉脱壳”?
736
2026-04-29
【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白
1418
2026-04-21
【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点
1072
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
886
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
942
2026-04-21
【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案
1289
2026-04-21
【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点
1179
2026-04-21
【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用
1836
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14962
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11569
2026-09-21
南美超级胎牛血清999尝鲜特惠





